{
    "clinical_study": {
        "@rank": "80695", 
        "arm_group": [
            {
                "arm_group_label": "Sativex", 
                "arm_group_type": "Active Comparator", 
                "description": "Contains delta-9-tetrahydrocannabinol (THC), 27 mg/mL:cannabidiol (CBD), 25 mg/mL, in ethanol:propylene glycol (50:50) excipients, with peppermint oil (0.05%) flavouring. Each actuation delivers THC 2.7 mg and CBD 2.5 mg.\nDose: 100 \u00b5L oromucosal spray to be administered up to a maximum of 12 sprays per day. There was an initial dose-titration period during which patients gradually increased their dose of study drug according to individual response and tolerability."
            }, 
            {
                "arm_group_label": "Placebo", 
                "arm_group_type": "Placebo Comparator", 
                "description": "Oromucosal spray, containing ethanol:propylene glycol (50:50) excipients, with peppermint oil (0.05%) flavouring and colourings FD&C Yellow No.5 (E102 tartrazine) (0.0260%), FD&C Yellow No.6 (E110 sunset yellow) (0.0038%), FD&C Red No. 40 (E129 Allura red AC) (0.00330%) and FD&C Blue No.1 (E133 Brilliant blue FCF) (0.00058%). Dose: 100 \u00b5L oromucosal spray to be administered up to a maximum of 12 sprays per day. There was an initial dose-titration period during which patients gradually increased their dose of study drug according to individual response and tolerability."
            }
        ], 
        "brief_summary": {
            "textblock": "A study to compare the change in cognitive performance and psychological status of patients\n      with spasticity due to Multiple Sclerosis when treated with Sativex or placebo, added to\n      existing anti-spasticity therapy over a period of 48 weeks. Secondary objectives were to\n      evaluate the effect of Sativex on mood and spasticity and to assess the safety and\n      tolerability of Sativex."
        }, 
        "brief_title": "A Randomized Study of Sativex on Cognitive Function and Mood: Multiple Sclerosis Patients", 
        "clinical_results": {
            "baseline": {
                "group_list": {
                    "group": [
                        {
                            "@group_id": "B1", 
                            "description": "Each 100 \u03bcl actuation contains THC (27 mg/mL) and CBD (25 mg/mL). The maximum permitted dose was 12 actuations (32.4 mg THC + 30 mg CBD) in any 24 hour period.", 
                            "title": "Sativex"
                        }, 
                        {
                            "@group_id": "B2", 
                            "description": "Each 100 \u03bcl actuation contains no active drug but colorants and excipients. The maximum permitted dose was 12 actuations in any 24 hour period.", 
                            "title": "Placebo"
                        }, 
                        {
                            "@group_id": "B3", 
                            "description": "Total of all reporting groups", 
                            "title": "Total"
                        }
                    ]
                }, 
                "measure_list": {
                    "measure": [
                        {
                            "category_list": {
                                "category": {
                                    "measurement_list": {
                                        "measurement": [
                                            {
                                                "@group_id": "B1", 
                                                "@value": "62"
                                            }, 
                                            {
                                                "@group_id": "B2", 
                                                "@value": "59"
                                            }, 
                                            {
                                                "@group_id": "B3", 
                                                "@value": "121"
                                            }
                                        ]
                                    }
                                }
                            }, 
                            "param": "Number", 
                            "title": "Number of Participants", 
                            "units": "participants"
                        }, 
                        {
                            "category_list": {
                                "category": [
                                    {
                                        "measurement_list": {
                                            "measurement": [
                                                {
                                                    "@group_id": "B1", 
                                                    "@value": "0"
                                                }, 
                                                {
                                                    "@group_id": "B2", 
                                                    "@value": "0"
                                                }, 
                                                {
                                                    "@group_id": "B3", 
                                                    "@value": "0"
                                                }
                                            ]
                                        }, 
                                        "sub_title": "<=18 years"
                                    }, 
                                    {
                                        "measurement_list": {
                                            "measurement": [
                                                {
                                                    "@group_id": "B1", 
                                                    "@value": "61"
                                                }, 
                                                {
                                                    "@group_id": "B2", 
                                                    "@value": "58"
                                                }, 
                                                {
                                                    "@group_id": "B3", 
                                                    "@value": "119"
                                                }
                                            ]
                                        }, 
                                        "sub_title": "Between 18 and 65 years"
                                    }, 
                                    {
                                        "measurement_list": {
                                            "measurement": [
                                                {
                                                    "@group_id": "B1", 
                                                    "@value": "1"
                                                }, 
                                                {
                                                    "@group_id": "B2", 
                                                    "@value": "1"
                                                }, 
                                                {
                                                    "@group_id": "B3", 
                                                    "@value": "2"
                                                }
                                            ]
                                        }, 
                                        "sub_title": ">=65 years"
                                    }
                                ]
                            }, 
                            "param": "Number", 
                            "title": "Age", 
                            "units": "participants"
                        }, 
                        {
                            "category_list": {
                                "category": {
                                    "measurement_list": {
                                        "measurement": [
                                            {
                                                "@group_id": "B1", 
                                                "@spread": "8.954", 
                                                "@value": "48.95"
                                            }, 
                                            {
                                                "@group_id": "B2", 
                                                "@spread": "10.381", 
                                                "@value": "48.21"
                                            }, 
                                            {
                                                "@group_id": "B3", 
                                                "@spread": "9.642", 
                                                "@value": "48.59"
                                            }
                                        ]
                                    }
                                }
                            }, 
                            "dispersion": "Standard Deviation", 
                            "param": "Mean", 
                            "title": "Age", 
                            "units": "years"
                        }, 
                        {
                            "category_list": {
                                "category": [
                                    {
                                        "measurement_list": {
                                            "measurement": [
                                                {
                                                    "@group_id": "B1", 
                                                    "@value": "39"
                                                }, 
                                                {
                                                    "@group_id": "B2", 
                                                    "@value": "37"
                                                }, 
                                                {
                                                    "@group_id": "B3", 
                                                    "@value": "76"
                                                }
                                            ]
                                        }, 
                                        "sub_title": "Female"
                                    }, 
                                    {
                                        "measurement_list": {
                                            "measurement": [
                                                {
                                                    "@group_id": "B1", 
                                                    "@value": "23"
                                                }, 
                                                {
                                                    "@group_id": "B2", 
                                                    "@value": "22"
                                                }, 
                                                {
                                                    "@group_id": "B3", 
                                                    "@value": "45"
                                                }
                                            ]
                                        }, 
                                        "sub_title": "Male"
                                    }
                                ]
                            }, 
                            "param": "Number", 
                            "title": "Gender", 
                            "units": "participants"
                        }, 
                        {
                            "category_list": {
                                "category": {
                                    "measurement_list": {
                                        "measurement": [
                                            {
                                                "@group_id": "B1", 
                                                "@value": "62"
                                            }, 
                                            {
                                                "@group_id": "B2", 
                                                "@value": "59"
                                            }, 
                                            {
                                                "@group_id": "B3", 
                                                "@value": "121"
                                            }
                                        ]
                                    }, 
                                    "sub_title": "Czech Republic"
                                }
                            }, 
                            "param": "Number", 
                            "title": "Region of Enrollment", 
                            "units": "participants"
                        }
                    ]
                }
            }, 
            "certain_agreements": {
                "pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.", 
                "restrictive_agreement": "GW Pharma Ltd (GW) will coordinate the dissemination of data from this study and may solicit input and assistance from the principal investigator. All publications, for example manuscripts, abstracts, oral/slide presentations or book chapters based on this study, must be submitted to GW for corporate review before release."
            }, 
            "outcome_list": {
                "outcome": [
                    {
                        "analysis_list": {
                            "analysis": {
                                "ci_lower_limit": "-6.41", 
                                "ci_n_sides": "1-Sided", 
                                "ci_percent": "97.5", 
                                "dispersion_type": "Standard Error of the mean", 
                                "dispersion_value": "2.492", 
                                "group_id_list": {
                                    "group_id": [
                                        "O1", 
                                        "O2"
                                    ]
                                }, 
                                "groups_desc": "The change at end of treatment was compared between treatment groups using ANCOVA. The model included treatment group and center grouping as factors and the baseline score as covariate. The planned sample size was 120 participants(60 patients in the Sativex arm and 60 in the placebo arm).", 
                                "non_inferiority": "Yes", 
                                "non_inferiority_desc": "The sample size is adequate to confirm the non-inferiority of Sativex with a clinical relevant reduction delta of 10%, assuming there is no difference between treatments in the actual change in cognition and also assuming a standard deviation for treatment difference of 10, using a one-tailed 2.5% significance level and power of 90%. Sativex is deemed to be non-inferior to placebo if the lower 1-sided 97.5% CI of the estimated mean treatment difference (Sativex-Placebo) is greater than -10%.", 
                                "param_type": "Estimated mean treatment difference", 
                                "param_value": "-1.47"
                            }
                        }, 
                        "description": "The PASAT is a measure of cognitive function that specifically assesses auditory information processing speed and flexibility, as well as calculation ability. Stimulus presentation rates were adapted for use with multiple sclerosis patients. The PASAT is presented on audio compact disk to control the rate of stimulus presentation. Single digits are presented either every 3 seconds (PASAT 1) or every 2 seconds (PASAT 2), and the patient must add each new digit to the one immediately prior to it. The test score is the sum of the total number of correct sums given (out of 60 possible) in each trial. An increase in score indicates an improvement in condition.", 
                        "group_list": {
                            "group": [
                                {
                                    "@group_id": "O1", 
                                    "description": "Each 100 \u03bcl actuation contains THC (27 mg/mL) and CBD (25 mg/mL). The maximum permitted dose was 12 actuations (32.4 mg THC + 30 mg CBD) in any 24 hour period.", 
                                    "title": "Sativex"
                                }, 
                                {
                                    "@group_id": "O2", 
                                    "description": "Each 100 \u03bcl actuation contains no active drug but colorants and excipients. The maximum permitted dose was 12 actuations in any 24 hour period.", 
                                    "title": "Placebo"
                                }
                            ]
                        }, 
                        "measure_list": {
                            "measure": [
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": [
                                                    {
                                                        "@group_id": "O1", 
                                                        "@value": "55"
                                                    }, 
                                                    {
                                                        "@group_id": "O2", 
                                                        "@value": "52"
                                                    }
                                                ]
                                            }
                                        }
                                    }, 
                                    "param": "Number", 
                                    "title": "Number of Participants", 
                                    "units": "participants"
                                }, 
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": [
                                                    {
                                                        "@group_id": "O1", 
                                                        "@spread": "16.16", 
                                                        "@value": "6.8"
                                                    }, 
                                                    {
                                                        "@group_id": "O2", 
                                                        "@spread": "13.49", 
                                                        "@value": "6.8"
                                                    }
                                                ]
                                            }
                                        }
                                    }, 
                                    "description": "The PASAT is a measure of cognitive function that specifically assesses auditory information processing speed and flexibility, as well as calculation ability. Stimulus presentation rates were adapted for use with multiple sclerosis patients. The PASAT is presented on audio compact disk to control the rate of stimulus presentation. Single digits are presented either every 3 seconds (PASAT 1) or every 2 seconds (PASAT 2), and the patient must add each new digit to the one immediately prior to it. The test score is the sum of the total number of correct sums given (out of 60 possible) in each trial. An increase in score indicates an improvement in condition.", 
                                    "dispersion": "Standard Deviation", 
                                    "param": "Mean", 
                                    "title": "Change From Baseline to the End of Treatment in Paced Auditory Serial Addition Test (PASAT) Total Score.", 
                                    "units": "units on a scale"
                                }
                            ]
                        }, 
                        "population": "All randomized patients who received at least one dose of study medication and yielded on-treatment efficacy data were included in the analysis.", 
                        "safety_issue": "Yes", 
                        "time_frame": "0-48 weeks", 
                        "title": "Change From Baseline to the End of Treatment in Paced Auditory Serial Addition Test (PASAT) Total Score.", 
                        "type": "Primary"
                    }, 
                    {
                        "analysis_list": {
                            "analysis": {
                                "ci_n_sides": "1-Sided", 
                                "ci_percent": "97.5", 
                                "ci_upper_limit": "2.33", 
                                "dispersion_type": "Standard Error of the mean", 
                                "dispersion_value": "1.323", 
                                "group_id_list": {
                                    "group_id": [
                                        "O1", 
                                        "O2"
                                    ]
                                }, 
                                "groups_desc": "The change at end of treatment was compared between treatment groups using ANCOVA. The model included treatment group and center grouping as factors and the baseline score as covariate.", 
                                "non_inferiority": "Yes", 
                                "non_inferiority_desc": "Sativex is deemed to be non-inferior to placebo if the upper 1-sided 97.5% CI of the estimated mean treatment difference (Sativex-Placebo) is less than +5%.", 
                                "param_type": "Estimated mean treatment difference", 
                                "param_value": "-0.29"
                            }
                        }, 
                        "description": "The BDI-II is a multiple choice self-reported inventory that is one of the most widely used instruments for measuring the severity of depression. There are 21 questions or items, each having four possible responses. Each response is assigned a score ranging from zero to three, indicating the severity of the symptom. Items 1 to 13 assess symptoms that are psychological in nature, while items 14 to 21 assess symptoms that are more physical. The sum of all BDI-II item scores indicates the severity of depression. For patients eligible for this study, a score of 21 or over represents depression. The BDI-II can distinguish between different subtypes of depressive disorders, such as major depression and dysthymia. A reduction in score indicates an improvement in condition.", 
                        "group_list": {
                            "group": [
                                {
                                    "@group_id": "O1", 
                                    "description": "Each 100 \u03bcl actuation contains THC (27 mg/mL) and CBD (25 mg/mL). The maximum permitted dose was 12 actuations (32.4 mg THC + 30 mg CBD) in any 24 hour period.", 
                                    "title": "Sativex"
                                }, 
                                {
                                    "@group_id": "O2", 
                                    "description": "Each 100 \u03bcl actuation contains no active drug but colorants and excipients. The maximum permitted dose was 12 actuations in any 24 hour period.", 
                                    "title": "Placebo"
                                }
                            ]
                        }, 
                        "measure_list": {
                            "measure": [
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": [
                                                    {
                                                        "@group_id": "O1", 
                                                        "@value": "57"
                                                    }, 
                                                    {
                                                        "@group_id": "O2", 
                                                        "@value": "56"
                                                    }
                                                ]
                                            }
                                        }
                                    }, 
                                    "param": "Number", 
                                    "title": "Number of Participants", 
                                    "units": "participants"
                                }, 
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": [
                                                    {
                                                        "@group_id": "O1", 
                                                        "@spread": "7.76", 
                                                        "@value": "-3.1"
                                                    }, 
                                                    {
                                                        "@group_id": "O2", 
                                                        "@spread": "6.38", 
                                                        "@value": "-2.4"
                                                    }
                                                ]
                                            }
                                        }
                                    }, 
                                    "description": "The BDI-II is a multiple choice self-reported inventory that is one of the most widely used instruments for measuring the severity of depression. There are 21 questions or items, each having four possible responses. Each response is assigned a score ranging from zero to three, indicating the severity of the symptom. Items 1 to 13 assess symptoms that are psychological in nature, while items 14 to 21 assess symptoms that are more physical. The sum of all BDI-II item scores indicates the severity of depression. For patients eligible for this study, a score of 21 or over represents depression. The BDI-II can distinguish between different subtypes of depressive disorders, such as major depression and dysthymia. A reduction in score indicates an improvement in condition.", 
                                    "dispersion": "Standard Deviation", 
                                    "param": "Mean", 
                                    "title": "Change From Baseline to the End of Treatment in Beck Depression Inventory-II (BDI-II) Total Score.", 
                                    "units": "units on a scale"
                                }
                            ]
                        }, 
                        "population": "All randomized patients who received at least one dose of study medication and yielded on-treatment efficacy data were included in the analysis.", 
                        "safety_issue": "Yes", 
                        "time_frame": "0-48 weeks", 
                        "title": "Change From Baseline to the End of Treatment in Beck Depression Inventory-II (BDI-II) Total Score.", 
                        "type": "Secondary"
                    }, 
                    {
                        "analysis_list": {
                            "analysis": {
                                "ci_lower_limit": "1.96", 
                                "ci_n_sides": "2-Sided", 
                                "ci_percent": "95", 
                                "ci_upper_limit": "8.22", 
                                "group_id_list": {
                                    "group_id": [
                                        "O1", 
                                        "O2"
                                    ]
                                }, 
                                "groups_desc": "Data were analysed using ordinal logistic regression using the cumulative proportional odds model, with global impression of change as the dependent variable and treatment group as factor.", 
                                "method": "Regression, Logistic", 
                                "non_inferiority": "No", 
                                "p_value": "0.0001", 
                                "param_type": "Odds Ratio (OR)", 
                                "param_value": "4.02"
                            }
                        }, 
                        "description": "Patients were asked the following question, to be rated on a seven-point scale:\n\"Please assess the change in your spasticity since immediately before receiving the first dose of study treatment (Visit 1) using the scale below\".\nThe markers were: 'Very much worse', 'Much worse', 'Minimally worse', 'No change', 'Minimally better', 'Much better' or 'Very much better'.\nThe number of patients for each of the markers is presented at the final study visit.", 
                        "group_list": {
                            "group": [
                                {
                                    "@group_id": "O1", 
                                    "description": "Each 100 \u03bcl actuation contains THC (27 mg/mL) and CBD (25 mg/mL). The maximum permitted dose was 12 actuations (32.4 mg THC + 30 mg CBD) in any 24 hour period.", 
                                    "title": "Sativex"
                                }, 
                                {
                                    "@group_id": "O2", 
                                    "description": "Each 100 \u03bcl actuation contains no active drug but colorants and excipients. The maximum permitted dose was 12 actuations in any 24 hour period.", 
                                    "title": "Placebo"
                                }
                            ]
                        }, 
                        "measure_list": {
                            "measure": [
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": [
                                                    {
                                                        "@group_id": "O1", 
                                                        "@value": "58"
                                                    }, 
                                                    {
                                                        "@group_id": "O2", 
                                                        "@value": "56"
                                                    }
                                                ]
                                            }
                                        }
                                    }, 
                                    "param": "Number", 
                                    "title": "Number of Participants", 
                                    "units": "participants"
                                }, 
                                {
                                    "category_list": {
                                        "category": [
                                            {
                                                "measurement_list": {
                                                    "measurement": [
                                                        {
                                                            "@group_id": "O1", 
                                                            "@value": "2"
                                                        }, 
                                                        {
                                                            "@group_id": "O2", 
                                                            "@value": "0"
                                                        }
                                                    ]
                                                }, 
                                                "sub_title": "Very Much Better"
                                            }, 
                                            {
                                                "measurement_list": {
                                                    "measurement": [
                                                        {
                                                            "@group_id": "O1", 
                                                            "@value": "16"
                                                        }, 
                                                        {
                                                            "@group_id": "O2", 
                                                            "@value": "6"
                                                        }
                                                    ]
                                                }, 
                                                "sub_title": "Much Better"
                                            }, 
                                            {
                                                "measurement_list": {
                                                    "measurement": [
                                                        {
                                                            "@group_id": "O1", 
                                                            "@value": "24"
                                                        }, 
                                                        {
                                                            "@group_id": "O2", 
                                                            "@value": "15"
                                                        }
                                                    ]
                                                }, 
                                                "sub_title": "Minimally Better"
                                            }, 
                                            {
                                                "measurement_list": {
                                                    "measurement": [
                                                        {
                                                            "@group_id": "O1", 
                                                            "@value": "13"
                                                        }, 
                                                        {
                                                            "@group_id": "O2", 
                                                            "@value": "27"
                                                        }
                                                    ]
                                                }, 
                                                "sub_title": "No Change"
                                            }, 
                                            {
                                                "measurement_list": {
                                                    "measurement": [
                                                        {
                                                            "@group_id": "O1", 
                                                            "@value": "1"
                                                        }, 
                                                        {
                                                            "@group_id": "O2", 
                                                            "@value": "7"
                                                        }
                                                    ]
                                                }, 
                                                "sub_title": "Minimally Worse"
                                            }, 
                                            {
                                                "measurement_list": {
                                                    "measurement": [
                                                        {
                                                            "@group_id": "O1", 
                                                            "@value": "2"
                                                        }, 
                                                        {
                                                            "@group_id": "O2", 
                                                            "@value": "1"
                                                        }
                                                    ]
                                                }, 
                                                "sub_title": "Much Worse"
                                            }, 
                                            {
                                                "measurement_list": {
                                                    "measurement": [
                                                        {
                                                            "@group_id": "O1", 
                                                            "@value": "0"
                                                        }, 
                                                        {
                                                            "@group_id": "O2", 
                                                            "@value": "0"
                                                        }
                                                    ]
                                                }, 
                                                "sub_title": "Very Much Worse"
                                            }
                                        ]
                                    }, 
                                    "description": "Patients were asked the following question, to be rated on a seven-point scale:\n\"Please assess the change in your spasticity since immediately before receiving the first dose of study treatment (Visit 1) using the scale below\".\nThe markers were: 'Very much worse', 'Much worse', 'Minimally worse', 'No change', 'Minimally better', 'Much better' or 'Very much better'.\nThe number of patients for each of the markers is presented at the final study visit.", 
                                    "param": "Number", 
                                    "title": "Subject Global Impression of Change (SGIC) in the Severity of Their Spasticity at the End of Treatment.", 
                                    "units": "participants"
                                }
                            ]
                        }, 
                        "population": "All randomized patients who received at least one dose of study medication and yielded on-treatment efficacy data were included in the analysis.", 
                        "safety_issue": "No", 
                        "time_frame": "0-48 weeks", 
                        "title": "Subject Global Impression of Change (SGIC) in the Severity of Their Spasticity at the End of Treatment.", 
                        "type": "Secondary"
                    }, 
                    {
                        "analysis_list": {
                            "analysis": {
                                "ci_lower_limit": "1.23", 
                                "ci_n_sides": "2-Sided", 
                                "ci_percent": "95", 
                                "ci_upper_limit": "6.31", 
                                "group_id_list": {
                                    "group_id": [
                                        "O1", 
                                        "O2"
                                    ]
                                }, 
                                "groups_desc": "Data were analysed using ordinal logistic regression using the cumulative proportional odds model, with global impression of change as the dependent variable and treatment group as factor.", 
                                "method": "Regression, Logistic", 
                                "non_inferiority": "No", 
                                "p_value": "0.0142", 
                                "param_type": "Odds Ratio (OR)", 
                                "param_value": "2.79"
                            }
                        }, 
                        "description": "Caregivers were asked the following question to be rated on a seven-point scale:\n\"How has the subject's spasticity changed since Visit 1?\" The markers were: Very much worse, Much worse, Minimally worse, No change, Minimally better, Much better, Very much better.\nThe number of patients for each of the markers is presented at the final study visit.", 
                        "group_list": {
                            "group": [
                                {
                                    "@group_id": "O1", 
                                    "description": "Each 100 \u03bcl actuation contains THC (27 mg/mL) and CBD (25 mg/mL). The maximum permitted dose was 12 actuations (32.4 mg THC + 30 mg CBD) in any 24 hour period.", 
                                    "title": "Sativex"
                                }, 
                                {
                                    "@group_id": "O2", 
                                    "description": "Each 100 \u03bcl actuation contains no active drug but colorants and excipients. The maximum permitted dose was 12 actuations in any 24 hour period.", 
                                    "title": "Placebo"
                                }
                            ]
                        }, 
                        "measure_list": {
                            "measure": [
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": [
                                                    {
                                                        "@group_id": "O1", 
                                                        "@value": "41"
                                                    }, 
                                                    {
                                                        "@group_id": "O2", 
                                                        "@value": "40"
                                                    }
                                                ]
                                            }
                                        }
                                    }, 
                                    "param": "Number", 
                                    "title": "Number of Participants", 
                                    "units": "participants"
                                }, 
                                {
                                    "category_list": {
                                        "category": [
                                            {
                                                "measurement_list": {
                                                    "measurement": [
                                                        {
                                                            "@group_id": "O1", 
                                                            "@value": "1"
                                                        }, 
                                                        {
                                                            "@group_id": "O2", 
                                                            "@value": "0"
                                                        }
                                                    ]
                                                }, 
                                                "sub_title": "Very Much Better"
                                            }, 
                                            {
                                                "measurement_list": {
                                                    "measurement": [
                                                        {
                                                            "@group_id": "O1", 
                                                            "@value": "12"
                                                        }, 
                                                        {
                                                            "@group_id": "O2", 
                                                            "@value": "6"
                                                        }
                                                    ]
                                                }, 
                                                "sub_title": "Much Better"
                                            }, 
                                            {
                                                "measurement_list": {
                                                    "measurement": [
                                                        {
                                                            "@group_id": "O1", 
                                                            "@value": "14"
                                                        }, 
                                                        {
                                                            "@group_id": "O2", 
                                                            "@value": "10"
                                                        }
                                                    ]
                                                }, 
                                                "sub_title": "Minimally Better"
                                            }, 
                                            {
                                                "measurement_list": {
                                                    "measurement": [
                                                        {
                                                            "@group_id": "O1", 
                                                            "@value": "11"
                                                        }, 
                                                        {
                                                            "@group_id": "O2", 
                                                            "@value": "18"
                                                        }
                                                    ]
                                                }, 
                                                "sub_title": "No Change"
                                            }, 
                                            {
                                                "measurement_list": {
                                                    "measurement": [
                                                        {
                                                            "@group_id": "O1", 
                                                            "@value": "3"
                                                        }, 
                                                        {
                                                            "@group_id": "O2", 
                                                            "@value": "3"
                                                        }
                                                    ]
                                                }, 
                                                "sub_title": "Minimally Worse"
                                            }, 
                                            {
                                                "measurement_list": {
                                                    "measurement": [
                                                        {
                                                            "@group_id": "O1", 
                                                            "@value": "0"
                                                        }, 
                                                        {
                                                            "@group_id": "O2", 
                                                            "@value": "3"
                                                        }
                                                    ]
                                                }, 
                                                "sub_title": "Much Worse"
                                            }, 
                                            {
                                                "measurement_list": {
                                                    "measurement": [
                                                        {
                                                            "@group_id": "O1", 
                                                            "@value": "0"
                                                        }, 
                                                        {
                                                            "@group_id": "O2", 
                                                            "@value": "0"
                                                        }
                                                    ]
                                                }, 
                                                "sub_title": "Very Much Worse"
                                            }
                                        ]
                                    }, 
                                    "description": "Caregivers were asked the following question to be rated on a seven-point scale:\n\"How has the subject's spasticity changed since Visit 1?\" The markers were: Very much worse, Much worse, Minimally worse, No change, Minimally better, Much better, Very much better.\nThe number of patients for each of the markers is presented at the final study visit.", 
                                    "param": "Number", 
                                    "title": "Caregiver's Global Impression of Change (CGIC) in the Severity of the Patient's Spasticity at the End of Treatment.", 
                                    "units": "participants"
                                }
                            ]
                        }, 
                        "population": "All randomized patients who received at least one dose of study medication and yielded on-treatment efficacy data were included in the analysis.", 
                        "safety_issue": "No", 
                        "time_frame": "0-48 weeks", 
                        "title": "Caregiver's Global Impression of Change (CGIC) in the Severity of the Patient's Spasticity at the End of Treatment.", 
                        "type": "Secondary"
                    }, 
                    {
                        "analysis_list": {
                            "analysis": {
                                "ci_lower_limit": "1.51", 
                                "ci_n_sides": "2-Sided", 
                                "ci_percent": "95", 
                                "ci_upper_limit": "6.21", 
                                "group_id_list": {
                                    "group_id": [
                                        "O1", 
                                        "O2"
                                    ]
                                }, 
                                "groups_desc": "Data were analysed using ordinal logistic regression using the cumulative proportional odds model, with global impression of change as the dependent variable and treatment group as factor.", 
                                "method": "Regression, Logistic", 
                                "non_inferiority": "No", 
                                "p_value": "0.0019", 
                                "param_type": "Odds Ratio (OR)", 
                                "param_value": "3.07"
                            }
                        }, 
                        "description": "Physicians were asked the following question to be rated on a seven-point scale:\n\"How has the subject's spasticity changed since Visit 1?\" The markers were: Very much worse, Much worse, Minimally worse, No change, Minimally better, Much better, Very much better.\nThe number of patients for each of the markers is presented at the final study visit.", 
                        "group_list": {
                            "group": [
                                {
                                    "@group_id": "O1", 
                                    "description": "Each 100 \u03bcl actuation contains THC (27 mg/mL) and CBD (25 mg/mL). The maximum permitted dose was 12 actuations (32.4 mg THC + 30 mg CBD) in any 24 hour period.", 
                                    "title": "Sativex"
                                }, 
                                {
                                    "@group_id": "O2", 
                                    "description": "Each 100 \u03bcl actuation contains no active drug but colorants and excipients. The maximum permitted dose was 12 actuations in any 24 hour period.", 
                                    "title": "Placebo"
                                }
                            ]
                        }, 
                        "measure_list": {
                            "measure": [
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": [
                                                    {
                                                        "@group_id": "O1", 
                                                        "@value": "58"
                                                    }, 
                                                    {
                                                        "@group_id": "O2", 
                                                        "@value": "56"
                                                    }
                                                ]
                                            }
                                        }
                                    }, 
                                    "param": "Number", 
                                    "title": "Number of Participants", 
                                    "units": "participants"
                                }, 
                                {
                                    "category_list": {
                                        "category": [
                                            {
                                                "measurement_list": {
                                                    "measurement": [
                                                        {
                                                            "@group_id": "O1", 
                                                            "@value": "0"
                                                        }, 
                                                        {
                                                            "@group_id": "O2", 
                                                            "@value": "1"
                                                        }
                                                    ]
                                                }, 
                                                "sub_title": "Very Much Better"
                                            }, 
                                            {
                                                "measurement_list": {
                                                    "measurement": [
                                                        {
                                                            "@group_id": "O1", 
                                                            "@value": "15"
                                                        }, 
                                                        {
                                                            "@group_id": "O2", 
                                                            "@value": "6"
                                                        }
                                                    ]
                                                }, 
                                                "sub_title": "Much Better"
                                            }, 
                                            {
                                                "measurement_list": {
                                                    "measurement": [
                                                        {
                                                            "@group_id": "O1", 
                                                            "@value": "26"
                                                        }, 
                                                        {
                                                            "@group_id": "O2", 
                                                            "@value": "15"
                                                        }
                                                    ]
                                                }, 
                                                "sub_title": "Minimally Better"
                                            }, 
                                            {
                                                "measurement_list": {
                                                    "measurement": [
                                                        {
                                                            "@group_id": "O1", 
                                                            "@value": "14"
                                                        }, 
                                                        {
                                                            "@group_id": "O2", 
                                                            "@value": "29"
                                                        }
                                                    ]
                                                }, 
                                                "sub_title": "No Change"
                                            }, 
                                            {
                                                "measurement_list": {
                                                    "measurement": [
                                                        {
                                                            "@group_id": "O1", 
                                                            "@value": "3"
                                                        }, 
                                                        {
                                                            "@group_id": "O2", 
                                                            "@value": "4"
                                                        }
                                                    ]
                                                }, 
                                                "sub_title": "Minimally Worse"
                                            }, 
                                            {
                                                "measurement_list": {
                                                    "measurement": [
                                                        {
                                                            "@group_id": "O1", 
                                                            "@value": "0"
                                                        }, 
                                                        {
                                                            "@group_id": "O2", 
                                                            "@value": "1"
                                                        }
                                                    ]
                                                }, 
                                                "sub_title": "Much Worse"
                                            }, 
                                            {
                                                "measurement_list": {
                                                    "measurement": [
                                                        {
                                                            "@group_id": "O1", 
                                                            "@value": "0"
                                                        }, 
                                                        {
                                                            "@group_id": "O2", 
                                                            "@value": "0"
                                                        }
                                                    ]
                                                }, 
                                                "sub_title": "Very Much Worse"
                                            }
                                        ]
                                    }, 
                                    "description": "Physicians were asked the following question to be rated on a seven-point scale:\n\"How has the subject's spasticity changed since Visit 1?\" The markers were: Very much worse, Much worse, Minimally worse, No change, Minimally better, Much better, Very much better.\nThe number of patients for each of the markers is presented at the final study visit.", 
                                    "param": "Number", 
                                    "title": "Physician's Global Impression of Change (PGIC) in the Severity of the Patient's Spasticity at the End of Treatment.", 
                                    "units": "participants"
                                }
                            ]
                        }, 
                        "population": "All randomized patients who received at least one dose of study medication and yielded on-treatment efficacy data were included in the analysis.", 
                        "safety_issue": "No", 
                        "time_frame": "0-48 weeks", 
                        "title": "Physician's Global Impression of Change (PGIC) in the Severity of the Patient's Spasticity at the End of Treatment.", 
                        "type": "Secondary"
                    }, 
                    {
                        "analysis_list": {
                            "analysis": {
                                "ci_lower_limit": "-6.09", 
                                "ci_n_sides": "2-Sided", 
                                "ci_percent": "95", 
                                "ci_upper_limit": "1.37", 
                                "dispersion_type": "Standard Error of the mean", 
                                "dispersion_value": "1.880", 
                                "group_id_list": {
                                    "group_id": [
                                        "O1", 
                                        "O2"
                                    ]
                                }, 
                                "groups_desc": "The change at end of treatment was compared between treatment groups using ANCOVA. The model included treatment group and center grouping as factors and the baseline score as covariate.", 
                                "method": "ANCOVA", 
                                "non_inferiority": "No", 
                                "p_value": "0.212", 
                                "param_type": "Estimated mean treatment difference", 
                                "param_value": "-2.36"
                            }
                        }, 
                        "description": "All 20 muscle groups were assessed for spasticity (using a 0-5 scale): 0= 'no increase in muscle tone' to 5= 'affected part(s) rigid in flexion or extension'. The score for all 20 muscle groups were added to give a total score out of 100. A decrease in score indicates an improvement in condition.", 
                        "group_list": {
                            "group": [
                                {
                                    "@group_id": "O1", 
                                    "description": "Each 100 \u03bcl actuation contains THC (27 mg/mL) and CBD (25 mg/mL). The maximum permitted dose was 12 actuations (32.4 mg THC + 30 mg CBD) in any 24 hour period.", 
                                    "title": "Sativex"
                                }, 
                                {
                                    "@group_id": "O2", 
                                    "description": "Each 100 \u03bcl actuation contains no active drug but colorants and excipients. The maximum permitted dose was 12 actuations in any 24 hour period.", 
                                    "title": "Placebo"
                                }
                            ]
                        }, 
                        "measure_list": {
                            "measure": [
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": [
                                                    {
                                                        "@group_id": "O1", 
                                                        "@value": "58"
                                                    }, 
                                                    {
                                                        "@group_id": "O2", 
                                                        "@value": "56"
                                                    }
                                                ]
                                            }
                                        }
                                    }, 
                                    "param": "Number", 
                                    "title": "Number of Participants", 
                                    "units": "participants"
                                }, 
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": [
                                                    {
                                                        "@group_id": "O1", 
                                                        "@spread": "11.26", 
                                                        "@value": "-10.6"
                                                    }, 
                                                    {
                                                        "@group_id": "O2", 
                                                        "@spread": "10.70", 
                                                        "@value": "-7.7"
                                                    }
                                                ]
                                            }
                                        }
                                    }, 
                                    "description": "All 20 muscle groups were assessed for spasticity (using a 0-5 scale): 0= 'no increase in muscle tone' to 5= 'affected part(s) rigid in flexion or extension'. The score for all 20 muscle groups were added to give a total score out of 100. A decrease in score indicates an improvement in condition.", 
                                    "dispersion": "Standard Deviation", 
                                    "param": "Mean", 
                                    "title": "Change From Baseline to End of Treatment in Modified Ashworth Scale Total Score.", 
                                    "units": "units on a scale"
                                }
                            ]
                        }, 
                        "population": "All randomized patients who received at least one dose of study medication and yielded on-treatment efficacy data were included in the analysis.", 
                        "safety_issue": "No", 
                        "time_frame": "0-48 weeks", 
                        "title": "Change From Baseline to End of Treatment in Modified Ashworth Scale Total Score.", 
                        "type": "Secondary"
                    }, 
                    {
                        "description": "At baseline, patients were asked how many times they had visited a healthcare professional in the previous 12 weeks. At subsequent visits, patients were asked how many times they had visited a healthcare professional since their last study visit. The change from baseline to the end of treatment is presented. A decrease in number indicates an improvement in condition.", 
                        "group_list": {
                            "group": [
                                {
                                    "@group_id": "O1", 
                                    "description": "Each 100 \u03bcl actuation contains THC (27 mg/mL) and CBD (25 mg/mL). The maximum permitted dose was 12 actuations (32.4 mg THC + 30 mg CBD) in any 24 hour period.", 
                                    "title": "Sativex"
                                }, 
                                {
                                    "@group_id": "O2", 
                                    "description": "Each 100 \u03bcl actuation contains no active drug but colorants and excipients. The maximum permitted dose was 12 actuations in any 24 hour period.", 
                                    "title": "Placebo"
                                }
                            ]
                        }, 
                        "measure_list": {
                            "measure": [
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": [
                                                    {
                                                        "@group_id": "O1", 
                                                        "@value": "58"
                                                    }, 
                                                    {
                                                        "@group_id": "O2", 
                                                        "@value": "56"
                                                    }
                                                ]
                                            }
                                        }
                                    }, 
                                    "param": "Number", 
                                    "title": "Number of Participants", 
                                    "units": "participants"
                                }, 
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": [
                                                    {
                                                        "@group_id": "O1", 
                                                        "@spread": "0.99", 
                                                        "@value": "-0.6"
                                                    }, 
                                                    {
                                                        "@group_id": "O2", 
                                                        "@spread": "1.30", 
                                                        "@value": "-0.4"
                                                    }
                                                ]
                                            }
                                        }
                                    }, 
                                    "description": "At baseline, patients were asked how many times they had visited a healthcare professional in the previous 12 weeks. At subsequent visits, patients were asked how many times they had visited a healthcare professional since their last study visit. The change from baseline to the end of treatment is presented. A decrease in number indicates an improvement in condition.", 
                                    "dispersion": "Standard Deviation", 
                                    "param": "Mean", 
                                    "title": "Change From Baseline to End of Treatment in Number of Visits to a Healthcare Professional.", 
                                    "units": "visits"
                                }
                            ]
                        }, 
                        "population": "All randomized patients who received at least one dose of study medication and yielded on-treatment efficacy data were included in the analysis.", 
                        "safety_issue": "No", 
                        "time_frame": "0-48 weeks", 
                        "title": "Change From Baseline to End of Treatment in Number of Visits to a Healthcare Professional.", 
                        "type": "Secondary"
                    }, 
                    {
                        "description": "Patients were scored at each clinic visit for the following outcomes using the C-SSRS: suicidal ideation, suicidal behaviour, suicidality (including complete suicidality). Possible flags were as follows: \"Wish to be Dead\", \"Non-specific Active Suicidal Thoughts\", \"Active Suicidal Ideation Without Intent\", \"Active Suicidal Ideation With Intent, No Plan\", \"Active Suicidal Ideation With Intent and Plan\". The number of patients with a treatment-emergent flag is presented.", 
                        "group_list": {
                            "group": [
                                {
                                    "@group_id": "O1", 
                                    "description": "Each 100 \u03bcl actuation contains THC (27 mg/mL) and CBD (25 mg/mL). The maximum permitted dose was 12 actuations (32.4 mg THC + 30 mg CBD) in any 24 hour period.", 
                                    "title": "Sativex"
                                }, 
                                {
                                    "@group_id": "O2", 
                                    "description": "Each 100 \u03bcl actuation contains no active drug but colorants and excipients. The maximum permitted dose was 12 actuations in any 24 hour period.", 
                                    "title": "Placebo"
                                }
                            ]
                        }, 
                        "measure_list": {
                            "measure": [
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": [
                                                    {
                                                        "@group_id": "O1", 
                                                        "@value": "62"
                                                    }, 
                                                    {
                                                        "@group_id": "O2", 
                                                        "@value": "59"
                                                    }
                                                ]
                                            }
                                        }
                                    }, 
                                    "param": "Number", 
                                    "title": "Number of Participants", 
                                    "units": "participants"
                                }, 
                                {
                                    "category_list": {
                                        "category": [
                                            {
                                                "measurement_list": {
                                                    "measurement": [
                                                        {
                                                            "@group_id": "O1", 
                                                            "@value": "0"
                                                        }, 
                                                        {
                                                            "@group_id": "O2", 
                                                            "@value": "2"
                                                        }
                                                    ]
                                                }, 
                                                "sub_title": "Wish to be Dead"
                                            }, 
                                            {
                                                "measurement_list": {
                                                    "measurement": [
                                                        {
                                                            "@group_id": "O1", 
                                                            "@value": "0"
                                                        }, 
                                                        {
                                                            "@group_id": "O2", 
                                                            "@value": "1"
                                                        }
                                                    ]
                                                }, 
                                                "sub_title": "Non-specific Active Suicidal Thoughts"
                                            }, 
                                            {
                                                "measurement_list": {
                                                    "measurement": [
                                                        {
                                                            "@group_id": "O1", 
                                                            "@value": "0"
                                                        }, 
                                                        {
                                                            "@group_id": "O2", 
                                                            "@value": "1"
                                                        }
                                                    ]
                                                }, 
                                                "sub_title": "Active Suicidal Ideation Without Intent"
                                            }, 
                                            {
                                                "measurement_list": {
                                                    "measurement": [
                                                        {
                                                            "@group_id": "O1", 
                                                            "@value": "0"
                                                        }, 
                                                        {
                                                            "@group_id": "O2", 
                                                            "@value": "0"
                                                        }
                                                    ]
                                                }, 
                                                "sub_title": "Active Suicidal Ideation With Intent, No Plan"
                                            }, 
                                            {
                                                "measurement_list": {
                                                    "measurement": [
                                                        {
                                                            "@group_id": "O1", 
                                                            "@value": "0"
                                                        }, 
                                                        {
                                                            "@group_id": "O2", 
                                                            "@value": "0"
                                                        }
                                                    ]
                                                }, 
                                                "sub_title": "Active Suicidal Ideation With Intent and Plan"
                                            }
                                        ]
                                    }, 
                                    "description": "Patients were scored at each clinic visit for the following outcomes using the C-SSRS: suicidal ideation, suicidal behaviour, suicidality (including complete suicidality). Possible flags were as follows: \"Wish to be Dead\", \"Non-specific Active Suicidal Thoughts\", \"Active Suicidal Ideation Without Intent\", \"Active Suicidal Ideation With Intent, No Plan\", \"Active Suicidal Ideation With Intent and Plan\". The number of patients with a treatment-emergent flag is presented.", 
                                    "param": "Number", 
                                    "title": "The Number of Patients With a Treatment-emergent Flag Using the Columbia-Suicide Severity Rating Scale (C-SSRS) During the Course of the Study.", 
                                    "units": "participants"
                                }
                            ]
                        }, 
                        "population": "All randomized patients who received at least one dose of study medication and yielded on-treatment efficacy data were included in the analysis.", 
                        "safety_issue": "Yes", 
                        "time_frame": "0-48 weeks", 
                        "title": "The Number of Patients With a Treatment-emergent Flag Using the Columbia-Suicide Severity Rating Scale (C-SSRS) During the Course of the Study.", 
                        "type": "Secondary"
                    }, 
                    {
                        "analysis_list": {
                            "analysis": [
                                {
                                    "ci_lower_limit": "-11.51", 
                                    "ci_n_sides": "2-Sided", 
                                    "ci_percent": "95", 
                                    "ci_upper_limit": "21.27", 
                                    "dispersion_type": "Standard Error of the mean", 
                                    "dispersion_value": "8.250", 
                                    "group_id_list": {
                                        "group_id": [
                                            "O1", 
                                            "O2"
                                        ]
                                    }, 
                                    "groups_desc": "The change at end of treatment was compared between treatment groups using ANCOVA. The model included treatment group and centre grouping as factors and baseline score as covariate.", 
                                    "method": "ANCOVA", 
                                    "non_inferiority": "No", 
                                    "p_value": "0.556", 
                                    "param_type": "Estimated mean treatment difference", 
                                    "param_value": "4.88"
                                }, 
                                {
                                    "ci_lower_limit": "-3", 
                                    "ci_n_sides": "2-Sided", 
                                    "ci_percent": "95", 
                                    "ci_upper_limit": "0", 
                                    "group_id_list": {
                                        "group_id": [
                                            "O1", 
                                            "O2"
                                        ]
                                    }, 
                                    "groups_desc": "The change at end of treatment was compared between treatment groups using non-parametric methods as the distribution of data was non-normal.", 
                                    "method": "Wilcoxon (Mann-Whitney)", 
                                    "non_inferiority": "No", 
                                    "p_value": "0.088", 
                                    "param_type": "Hodges-Lehmann median difference", 
                                    "param_value": "-1"
                                }
                            ]
                        }, 
                        "description": "Only those patients for whom it was appropriate (i.e. ambulatory patients) were timed for how long it took to walk 10 metres. If a patient started the 10-meter walk but was unable to complete it, an estimated time for completion was calculated based on the available data. A negative difference from baseline indicates an improvement in condition.", 
                        "group_list": {
                            "group": [
                                {
                                    "@group_id": "O1", 
                                    "description": "Each 100 \u03bcl actuation contains THC (27 mg/mL) and CBD (25 mg/mL). The maximum permitted dose was 12 actuations (32.4 mg THC + 30 mg CBD) in any 24 hour period.", 
                                    "title": "Sativex"
                                }, 
                                {
                                    "@group_id": "O2", 
                                    "description": "Each 100 \u03bcl actuation contains no active drug but colorants and excipients. The maximum permitted dose was 12 actuations in any 24 hour period.", 
                                    "title": "Placebo"
                                }
                            ]
                        }, 
                        "measure_list": {
                            "measure": [
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": [
                                                    {
                                                        "@group_id": "O1", 
                                                        "@value": "47"
                                                    }, 
                                                    {
                                                        "@group_id": "O2", 
                                                        "@value": "50"
                                                    }
                                                ]
                                            }
                                        }
                                    }, 
                                    "param": "Number", 
                                    "title": "Number of Participants", 
                                    "units": "participants"
                                }, 
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": [
                                                    {
                                                        "@group_id": "O1", 
                                                        "@spread": "55.34", 
                                                        "@value": "6.2"
                                                    }, 
                                                    {
                                                        "@group_id": "O2", 
                                                        "@spread": "24.68", 
                                                        "@value": "3.0"
                                                    }
                                                ]
                                            }
                                        }
                                    }, 
                                    "description": "Only those patients for whom it was appropriate (i.e. ambulatory patients) were timed for how long it took to walk 10 metres. If a patient started the 10-meter walk but was unable to complete it, an estimated time for completion was calculated based on the available data. A negative difference from baseline indicates an improvement in condition.", 
                                    "dispersion": "Standard Deviation", 
                                    "param": "Mean", 
                                    "title": "Change From Baseline to End of Treatment in Timed 10-meter Walk Times.", 
                                    "units": "seconds"
                                }
                            ]
                        }, 
                        "population": "All randomized patients who received at least one dose of study medication and yielded on-treatment efficacy data were included in the analysis.", 
                        "safety_issue": "No", 
                        "time_frame": "0-48 weeks", 
                        "title": "Change From Baseline to End of Treatment in Timed 10-meter Walk Times.", 
                        "type": "Secondary"
                    }, 
                    {
                        "description": "The number of subjects who experienced an adverse event during the course of the study is presented.", 
                        "group_list": {
                            "group": [
                                {
                                    "@group_id": "O1", 
                                    "description": "Each 100 \u03bcl actuation contains THC (27 mg/mL) and CBD (25 mg/mL). The maximum permitted dose was 12 actuations (32.4 mg THC + 30 mg CBD) in any 24 hour period.", 
                                    "title": "Sativex"
                                }, 
                                {
                                    "@group_id": "O2", 
                                    "description": "Each 100 \u03bcl actuation contains no active drug but colorants and excipients. The maximum permitted dose was 12 actuations in any 24 hour period.", 
                                    "title": "Placebo"
                                }
                            ]
                        }, 
                        "measure_list": {
                            "measure": [
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": [
                                                    {
                                                        "@group_id": "O1", 
                                                        "@value": "62"
                                                    }, 
                                                    {
                                                        "@group_id": "O2", 
                                                        "@value": "59"
                                                    }
                                                ]
                                            }
                                        }
                                    }, 
                                    "param": "Number", 
                                    "title": "Number of Participants", 
                                    "units": "participants"
                                }, 
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": [
                                                    {
                                                        "@group_id": "O1", 
                                                        "@value": "39"
                                                    }, 
                                                    {
                                                        "@group_id": "O2", 
                                                        "@value": "19"
                                                    }
                                                ]
                                            }
                                        }
                                    }, 
                                    "description": "The number of subjects who experienced an adverse event during the course of the study is presented.", 
                                    "param": "Number", 
                                    "title": "Incidence of Adverse Events as a Measure of Patient Safety.", 
                                    "units": "participants"
                                }
                            ]
                        }, 
                        "population": "All randomized patients who received at least one dose of study medication and yielded on-treatment efficacy data were included in the analysis.", 
                        "safety_issue": "Yes", 
                        "time_frame": "0-50 weeks", 
                        "title": "Incidence of Adverse Events as a Measure of Patient Safety.", 
                        "type": "Secondary"
                    }
                ]
            }, 
            "participant_flow": {
                "group_list": {
                    "group": [
                        {
                            "@group_id": "P1", 
                            "description": "Each 100 \u03bcl actuation contains delta-9-tetrahydrocannabinol (THC) (27 mg/mL) and CBD (25 mg/mL). The maximum permitted dose was 12 actuations (32.4 mg THC + 30 mg CBD) in any 24 hour period.", 
                            "title": "Sativex"
                        }, 
                        {
                            "@group_id": "P2", 
                            "description": "Each 100 \u03bcl actuation contains no active drug but colorants and excipients. The maximum permitted dose was 12 actuations in any 24 hour period.", 
                            "title": "Placebo"
                        }
                    ]
                }, 
                "period_list": {
                    "period": {
                        "drop_withdraw_reason_list": {
                            "drop_withdraw_reason": [
                                {
                                    "participants_list": {
                                        "participants": [
                                            {
                                                "@count": "8", 
                                                "@group_id": "P1"
                                            }, 
                                            {
                                                "@count": "2", 
                                                "@group_id": "P2"
                                            }
                                        ]
                                    }, 
                                    "title": "Adverse Event"
                                }, 
                                {
                                    "participants_list": {
                                        "participants": [
                                            {
                                                "@count": "4", 
                                                "@group_id": "P1"
                                            }, 
                                            {
                                                "@count": "7", 
                                                "@group_id": "P2"
                                            }
                                        ]
                                    }, 
                                    "title": "Withdrawal by Subject"
                                }, 
                                {
                                    "participants_list": {
                                        "participants": [
                                            {
                                                "@count": "0", 
                                                "@group_id": "P1"
                                            }, 
                                            {
                                                "@count": "1", 
                                                "@group_id": "P2"
                                            }
                                        ]
                                    }, 
                                    "title": "Lost to Follow-up"
                                }, 
                                {
                                    "participants_list": {
                                        "participants": [
                                            {
                                                "@count": "0", 
                                                "@group_id": "P1"
                                            }, 
                                            {
                                                "@count": "1", 
                                                "@group_id": "P2"
                                            }
                                        ]
                                    }, 
                                    "title": "Withdrawal by Investigator"
                                }
                            ]
                        }, 
                        "milestone_list": {
                            "milestone": [
                                {
                                    "participants_list": {
                                        "participants": [
                                            {
                                                "@count": "62", 
                                                "@group_id": "P1"
                                            }, 
                                            {
                                                "@count": "59", 
                                                "@group_id": "P2"
                                            }
                                        ]
                                    }, 
                                    "title": "STARTED"
                                }, 
                                {
                                    "participants_list": {
                                        "participants": [
                                            {
                                                "@count": "50", 
                                                "@group_id": "P1"
                                            }, 
                                            {
                                                "@count": "48", 
                                                "@group_id": "P2"
                                            }
                                        ]
                                    }, 
                                    "title": "COMPLETED"
                                }, 
                                {
                                    "participants_list": {
                                        "participants": [
                                            {
                                                "@count": "12", 
                                                "@group_id": "P1"
                                            }, 
                                            {
                                                "@count": "11", 
                                                "@group_id": "P2"
                                            }
                                        ]
                                    }, 
                                    "title": "NOT COMPLETED"
                                }
                            ]
                        }, 
                        "title": "Overall Study"
                    }
                }
            }, 
            "point_of_contact": {
                "email": "rp@gwpharm.com", 
                "name_or_title": "Mr Richard Potts, Clinical Operations Director", 
                "organization": "GW Pharma Ltd.", 
                "phone": "0044 1223 266800"
            }, 
            "reported_events": {
                "desc": "All adverse events occurring during the study were reported on the running logs at the back of the study case report form.", 
                "group_list": {
                    "group": [
                        {
                            "@group_id": "E1", 
                            "description": "Each 100 \u03bcl actuation contains THC (27 mg/mL) and CBD (25 mg/mL). The maximum permitted dose was 12 actuations (32.4 mg THC + 30 mg CBD) in any 24 hour period.", 
                            "title": "Sativex"
                        }, 
                        {
                            "@group_id": "E2", 
                            "description": "Each 100 \u03bcl actuation contains no active drug but colorants and excipients. The maximum permitted dose was 12 actuations in any 24 hour period.", 
                            "title": "Placebo"
                        }
                    ]
                }, 
                "other_events": {
                    "category_list": {
                        "category": [
                            {
                                "event_list": {
                                    "event": {
                                        "counts": [
                                            {
                                                "@group_id": "E1", 
                                                "@subjects_affected": "34", 
                                                "@subjects_at_risk": "62"
                                            }, 
                                            {
                                                "@group_id": "E2", 
                                                "@subjects_affected": "19", 
                                                "@subjects_at_risk": "59"
                                            }
                                        ], 
                                        "sub_title": "Total, other adverse events"
                                    }
                                }, 
                                "title": "Total"
                            }, 
                            {
                                "event_list": {
                                    "event": {
                                        "counts": [
                                            {
                                                "@group_id": "E1", 
                                                "@subjects_affected": "6", 
                                                "@subjects_at_risk": "62"
                                            }, 
                                            {
                                                "@group_id": "E2", 
                                                "@subjects_affected": "0", 
                                                "@subjects_at_risk": "59"
                                            }
                                        ], 
                                        "sub_title": "Vertigo"
                                    }
                                }, 
                                "title": "Ear and labyrinth disorders"
                            }, 
                            {
                                "event_list": {
                                    "event": {
                                        "counts": [
                                            {
                                                "@group_id": "E1", 
                                                "@subjects_affected": "0", 
                                                "@subjects_at_risk": "62"
                                            }, 
                                            {
                                                "@group_id": "E2", 
                                                "@subjects_affected": "1", 
                                                "@subjects_at_risk": "59"
                                            }
                                        ], 
                                        "sub_title": "Visual Impairment"
                                    }
                                }, 
                                "title": "Eye disorders"
                            }, 
                            {
                                "event_list": {
                                    "event": [
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "1", 
                                                    "@subjects_at_risk": "62"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "59"
                                                }
                                            ], 
                                            "sub_title": "Diarrhoea"
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "2", 
                                                    "@subjects_at_risk": "62"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "59"
                                                }
                                            ], 
                                            "sub_title": "Dry Mouth"
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "62"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "2", 
                                                    "@subjects_at_risk": "59"
                                                }
                                            ], 
                                            "sub_title": "Gingivitis"
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "1", 
                                                    "@subjects_at_risk": "62"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "1", 
                                                    "@subjects_at_risk": "59"
                                                }
                                            ], 
                                            "sub_title": "Nausea"
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "62"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "1", 
                                                    "@subjects_at_risk": "59"
                                                }
                                            ], 
                                            "sub_title": "Oral Mucosal Erythema"
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "1", 
                                                    "@subjects_at_risk": "62"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "59"
                                                }
                                            ], 
                                            "sub_title": "Vomiting"
                                        }
                                    ]
                                }, 
                                "title": "Gastrointestinal disorders"
                            }, 
                            {
                                "event_list": {
                                    "event": [
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "2", 
                                                    "@subjects_at_risk": "62"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "59"
                                                }
                                            ], 
                                            "sub_title": "Asthenia"
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "5", 
                                                    "@subjects_at_risk": "62"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "1", 
                                                    "@subjects_at_risk": "59"
                                                }
                                            ], 
                                            "sub_title": "Fatigue"
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "62"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "1", 
                                                    "@subjects_at_risk": "59"
                                                }
                                            ], 
                                            "sub_title": "Pyrexia"
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "1", 
                                                    "@subjects_at_risk": "62"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "59"
                                                }
                                            ], 
                                            "sub_title": "Application Site Discomfort"
                                        }
                                    ]
                                }, 
                                "title": "General disorders"
                            }, 
                            {
                                "event_list": {
                                    "event": {
                                        "counts": [
                                            {
                                                "@group_id": "E1", 
                                                "@subjects_affected": "0", 
                                                "@subjects_at_risk": "62"
                                            }, 
                                            {
                                                "@group_id": "E2", 
                                                "@subjects_affected": "1", 
                                                "@subjects_at_risk": "59"
                                            }
                                        ], 
                                        "sub_title": "Drug Hypersensitivity"
                                    }
                                }, 
                                "title": "Immune system disorders"
                            }, 
                            {
                                "event_list": {
                                    "event": [
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "1", 
                                                    "@subjects_at_risk": "62"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "59"
                                                }
                                            ], 
                                            "sub_title": "Bacterial Infection"
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "1", 
                                                    "@subjects_at_risk": "62"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "59"
                                                }
                                            ], 
                                            "sub_title": "Herpes Zoster"
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "62"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "1", 
                                                    "@subjects_at_risk": "59"
                                                }
                                            ], 
                                            "sub_title": "Subcutaneous Abscess"
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "2", 
                                                    "@subjects_at_risk": "62"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "59"
                                                }
                                            ], 
                                            "sub_title": "Tonsillitis"
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "62"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "3", 
                                                    "@subjects_at_risk": "59"
                                                }
                                            ], 
                                            "sub_title": "Upper Respiratory Tract Infection"
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "62"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "1", 
                                                    "@subjects_at_risk": "59"
                                                }
                                            ], 
                                            "sub_title": "Upper Respiratory Tract Infection Bacterial"
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "5", 
                                                    "@subjects_at_risk": "62"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "1", 
                                                    "@subjects_at_risk": "59"
                                                }
                                            ], 
                                            "sub_title": "Urinary Tract Infection"
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "62"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "2", 
                                                    "@subjects_at_risk": "59"
                                                }
                                            ], 
                                            "sub_title": "Viral Infection"
                                        }
                                    ]
                                }, 
                                "title": "Infections and infestations"
                            }, 
                            {
                                "event_list": {
                                    "event": [
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "1", 
                                                    "@subjects_at_risk": "62"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "1", 
                                                    "@subjects_at_risk": "59"
                                                }
                                            ], 
                                            "sub_title": "Contusion"
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "1", 
                                                    "@subjects_at_risk": "62"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "59"
                                                }
                                            ], 
                                            "sub_title": "Face Injury"
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "62"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "1", 
                                                    "@subjects_at_risk": "59"
                                                }
                                            ], 
                                            "sub_title": "Foot Fracture"
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "62"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "1", 
                                                    "@subjects_at_risk": "59"
                                                }
                                            ], 
                                            "sub_title": "Forearm Fracture"
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "1", 
                                                    "@subjects_at_risk": "62"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "1", 
                                                    "@subjects_at_risk": "59"
                                                }
                                            ], 
                                            "sub_title": "Joint Dislocation"
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "62"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "1", 
                                                    "@subjects_at_risk": "59"
                                                }
                                            ], 
                                            "sub_title": "Ligament Sprain"
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "1", 
                                                    "@subjects_at_risk": "62"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "59"
                                                }
                                            ], 
                                            "sub_title": "Lower Limb Fracture"
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "1", 
                                                    "@subjects_at_risk": "62"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "59"
                                                }
                                            ], 
                                            "sub_title": "Procedural Vomiting"
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "1", 
                                                    "@subjects_at_risk": "62"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "59"
                                                }
                                            ], 
                                            "sub_title": "Thermal Burn"
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "1", 
                                                    "@subjects_at_risk": "62"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "59"
                                                }
                                            ], 
                                            "sub_title": "Upper Limb Fracture"
                                        }
                                    ]
                                }, 
                                "title": "Injury, poisoning and procedural complications"
                            }, 
                            {
                                "event_list": {
                                    "event": [
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "62"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "1", 
                                                    "@subjects_at_risk": "59"
                                                }
                                            ], 
                                            "sub_title": "Blood Alkaline Phosphatase Increased"
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "62"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "1", 
                                                    "@subjects_at_risk": "59"
                                                }
                                            ], 
                                            "sub_title": "Vitamin D Decreased"
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "3", 
                                                    "@subjects_at_risk": "62"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "59"
                                                }
                                            ], 
                                            "sub_title": "Weight Decreased"
                                        }
                                    ]
                                }, 
                                "title": "Investigations"
                            }, 
                            {
                                "event_list": {
                                    "event": {
                                        "counts": [
                                            {
                                                "@group_id": "E1", 
                                                "@subjects_affected": "1", 
                                                "@subjects_at_risk": "62"
                                            }, 
                                            {
                                                "@group_id": "E2", 
                                                "@subjects_affected": "0", 
                                                "@subjects_at_risk": "59"
                                            }
                                        ], 
                                        "sub_title": "Decreased Appetite"
                                    }
                                }, 
                                "title": "Metabolism and nutrition disorders"
                            }, 
                            {
                                "event_list": {
                                    "event": [
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "1", 
                                                    "@subjects_at_risk": "62"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "59"
                                                }
                                            ], 
                                            "sub_title": "Back Pain"
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "1", 
                                                    "@subjects_at_risk": "62"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "59"
                                                }
                                            ], 
                                            "sub_title": "Muscle Spasms"
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "1", 
                                                    "@subjects_at_risk": "62"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "59"
                                                }
                                            ], 
                                            "sub_title": "Pain In Extremity"
                                        }
                                    ]
                                }, 
                                "title": "Musculoskeletal and connective tissue disorders"
                            }, 
                            {
                                "event_list": {
                                    "event": [
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "2", 
                                                    "@subjects_at_risk": "62"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "59"
                                                }
                                            ], 
                                            "sub_title": "Cerebellar Ataxia"
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "62"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "1", 
                                                    "@subjects_at_risk": "59"
                                                }
                                            ], 
                                            "sub_title": "Cognitive Disorder"
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "5", 
                                                    "@subjects_at_risk": "62"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "59"
                                                }
                                            ], 
                                            "sub_title": "Dizziness"
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "1", 
                                                    "@subjects_at_risk": "62"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "2", 
                                                    "@subjects_at_risk": "59"
                                                }
                                            ], 
                                            "sub_title": "Headache"
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "1", 
                                                    "@subjects_at_risk": "62"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "59"
                                                }
                                            ], 
                                            "sub_title": "Memory Impairment"
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "1", 
                                                    "@subjects_at_risk": "62"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "59"
                                                }
                                            ], 
                                            "sub_title": "Multiple Sclerosis"
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "3", 
                                                    "@subjects_at_risk": "62"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "4", 
                                                    "@subjects_at_risk": "59"
                                                }
                                            ], 
                                            "sub_title": "Multiple Sclerosis Relapse"
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "5", 
                                                    "@subjects_at_risk": "62"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "2", 
                                                    "@subjects_at_risk": "59"
                                                }
                                            ], 
                                            "sub_title": "Muscle Spasticity"
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "2", 
                                                    "@subjects_at_risk": "62"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "59"
                                                }
                                            ], 
                                            "sub_title": "Neuralgia"
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "1", 
                                                    "@subjects_at_risk": "62"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "1", 
                                                    "@subjects_at_risk": "59"
                                                }
                                            ], 
                                            "sub_title": "Paraesthesia"
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "62"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "1", 
                                                    "@subjects_at_risk": "59"
                                                }
                                            ], 
                                            "sub_title": "Paraparesis"
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "1", 
                                                    "@subjects_at_risk": "62"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "59"
                                                }
                                            ], 
                                            "sub_title": "Radiculopathy"
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "1", 
                                                    "@subjects_at_risk": "62"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "1", 
                                                    "@subjects_at_risk": "59"
                                                }
                                            ], 
                                            "sub_title": "Somnolence"
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "1", 
                                                    "@subjects_at_risk": "62"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "59"
                                                }
                                            ], 
                                            "sub_title": "Stupor"
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "1", 
                                                    "@subjects_at_risk": "62"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "59"
                                                }
                                            ], 
                                            "sub_title": "Tremor"
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "1", 
                                                    "@subjects_at_risk": "62"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "59"
                                                }
                                            ], 
                                            "sub_title": "Trigeminal Neuralgia"
                                        }
                                    ]
                                }, 
                                "title": "Nervous system disorders"
                            }, 
                            {
                                "event_list": {
                                    "event": [
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "2", 
                                                    "@subjects_at_risk": "62"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "59"
                                                }
                                            ], 
                                            "sub_title": "Anxiety Disorder Due To A General Medical Condition"
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "2", 
                                                    "@subjects_at_risk": "62"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "59"
                                                }
                                            ], 
                                            "sub_title": "Euphoric Mood"
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "62"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "1", 
                                                    "@subjects_at_risk": "59"
                                                }
                                            ], 
                                            "sub_title": "Suicidal Ideation"
                                        }
                                    ]
                                }, 
                                "title": "Psychiatric disorders"
                            }, 
                            {
                                "event_list": {
                                    "event": {
                                        "counts": [
                                            {
                                                "@group_id": "E1", 
                                                "@subjects_affected": "0", 
                                                "@subjects_at_risk": "62"
                                            }, 
                                            {
                                                "@group_id": "E2", 
                                                "@subjects_affected": "1", 
                                                "@subjects_at_risk": "59"
                                            }
                                        ], 
                                        "sub_title": "Erectile Dysfunction"
                                    }
                                }, 
                                "title": "Reproductive system and breast disorders"
                            }, 
                            {
                                "event_list": {
                                    "event": {
                                        "counts": [
                                            {
                                                "@group_id": "E1", 
                                                "@subjects_affected": "0", 
                                                "@subjects_at_risk": "62"
                                            }, 
                                            {
                                                "@group_id": "E2", 
                                                "@subjects_affected": "1", 
                                                "@subjects_at_risk": "59"
                                            }
                                        ], 
                                        "sub_title": "Oropharyngeal Blistering"
                                    }
                                }, 
                                "title": "Respiratory, thoracic and mediastinal disorders"
                            }, 
                            {
                                "event_list": {
                                    "event": {
                                        "counts": [
                                            {
                                                "@group_id": "E1", 
                                                "@subjects_affected": "1", 
                                                "@subjects_at_risk": "62"
                                            }, 
                                            {
                                                "@group_id": "E2", 
                                                "@subjects_affected": "0", 
                                                "@subjects_at_risk": "59"
                                            }
                                        ], 
                                        "sub_title": "Dermatitis Allergic"
                                    }
                                }, 
                                "title": "Skin and subcutaneous tissue disorders"
                            }, 
                            {
                                "event_list": {
                                    "event": [
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "62"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "1", 
                                                    "@subjects_at_risk": "59"
                                                }
                                            ], 
                                            "sub_title": "Lipoma Excision"
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "1", 
                                                    "@subjects_at_risk": "62"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "59"
                                                }
                                            ], 
                                            "sub_title": "Tooth Extraction"
                                        }
                                    ]
                                }, 
                                "title": "Surgical and medical procedures"
                            }
                        ]
                    }, 
                    "default_assessment": "Systematic Assessment", 
                    "default_vocab": "MedDRA 13.1", 
                    "frequency_threshold": "0"
                }, 
                "serious_events": {
                    "category_list": {
                        "category": [
                            {
                                "event_list": {
                                    "event": {
                                        "counts": [
                                            {
                                                "@group_id": "E1", 
                                                "@subjects_affected": "5", 
                                                "@subjects_at_risk": "62"
                                            }, 
                                            {
                                                "@group_id": "E2", 
                                                "@subjects_affected": "0", 
                                                "@subjects_at_risk": "59"
                                            }
                                        ], 
                                        "sub_title": "Total, serious adverse events"
                                    }
                                }, 
                                "title": "Total"
                            }, 
                            {
                                "event_list": {
                                    "event": {
                                        "counts": [
                                            {
                                                "@group_id": "E1", 
                                                "@subjects_affected": "1", 
                                                "@subjects_at_risk": "62"
                                            }, 
                                            {
                                                "@group_id": "E2", 
                                                "@subjects_affected": "0", 
                                                "@subjects_at_risk": "59"
                                            }
                                        ], 
                                        "description": "The acute myocardial infarction resulted in the affected participant's death; this was not considered to be treatment-related.", 
                                        "sub_title": "Acute Myocardial Infarction"
                                    }
                                }, 
                                "title": "Cardiac disorders"
                            }, 
                            {
                                "event_list": {
                                    "event": {
                                        "counts": [
                                            {
                                                "@group_id": "E1", 
                                                "@subjects_affected": "1", 
                                                "@subjects_at_risk": "62"
                                            }, 
                                            {
                                                "@group_id": "E2", 
                                                "@subjects_affected": "0", 
                                                "@subjects_at_risk": "59"
                                            }
                                        ], 
                                        "sub_title": "Inguinal Hernia"
                                    }
                                }, 
                                "title": "Gastrointestinal disorders"
                            }, 
                            {
                                "event_list": {
                                    "event": {
                                        "counts": [
                                            {
                                                "@group_id": "E1", 
                                                "@subjects_affected": "1", 
                                                "@subjects_at_risk": "62"
                                            }, 
                                            {
                                                "@group_id": "E2", 
                                                "@subjects_affected": "0", 
                                                "@subjects_at_risk": "59"
                                            }
                                        ], 
                                        "sub_title": "Drug Withdrawal Syndrome"
                                    }
                                }, 
                                "title": "General disorders"
                            }, 
                            {
                                "event_list": {
                                    "event": [
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "1", 
                                                    "@subjects_at_risk": "62"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "59"
                                                }
                                            ], 
                                            "sub_title": "Bronchitis"
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "1", 
                                                    "@subjects_at_risk": "62"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "59"
                                                }
                                            ], 
                                            "sub_title": "Pneumonia"
                                        }
                                    ]
                                }, 
                                "title": "Infections and infestations"
                            }, 
                            {
                                "event_list": {
                                    "event": {
                                        "counts": [
                                            {
                                                "@group_id": "E1", 
                                                "@subjects_affected": "1", 
                                                "@subjects_at_risk": "62"
                                            }, 
                                            {
                                                "@group_id": "E2", 
                                                "@subjects_affected": "0", 
                                                "@subjects_at_risk": "59"
                                            }
                                        ], 
                                        "sub_title": "Overdose"
                                    }
                                }, 
                                "title": "Injury, poisoning and procedural complications"
                            }, 
                            {
                                "event_list": {
                                    "event": {
                                        "counts": [
                                            {
                                                "@group_id": "E1", 
                                                "@subjects_affected": "1", 
                                                "@subjects_at_risk": "62"
                                            }, 
                                            {
                                                "@group_id": "E2", 
                                                "@subjects_affected": "0", 
                                                "@subjects_at_risk": "59"
                                            }
                                        ], 
                                        "sub_title": "Tetany"
                                    }
                                }, 
                                "title": "Metabolism and nutrition disorders"
                            }, 
                            {
                                "event_list": {
                                    "event": {
                                        "counts": [
                                            {
                                                "@group_id": "E1", 
                                                "@subjects_affected": "1", 
                                                "@subjects_at_risk": "62"
                                            }, 
                                            {
                                                "@group_id": "E2", 
                                                "@subjects_affected": "0", 
                                                "@subjects_at_risk": "59"
                                            }
                                        ], 
                                        "sub_title": "Dysarthria"
                                    }
                                }, 
                                "title": "Nervous system disorders"
                            }, 
                            {
                                "event_list": {
                                    "event": {
                                        "counts": [
                                            {
                                                "@group_id": "E1", 
                                                "@subjects_affected": "1", 
                                                "@subjects_at_risk": "62"
                                            }, 
                                            {
                                                "@group_id": "E2", 
                                                "@subjects_affected": "0", 
                                                "@subjects_at_risk": "59"
                                            }
                                        ], 
                                        "sub_title": "Disorientation"
                                    }
                                }, 
                                "title": "Psychiatric disorders"
                            }
                        ]
                    }, 
                    "default_assessment": "Systematic Assessment", 
                    "default_vocab": "MedDRA 13.1"
                }, 
                "time_frame": "All adverse events occurring during the study (0-50 weeks) were collected. All deaths and serious adverse events occurring within 28 days of the final dose of study medication were also collected."
            }
        }, 
        "completion_date": {
            "#text": "May 2013", 
            "@type": "Actual"
        }, 
        "condition": [
            "Multiple Sclerosis", 
            "Spasticity"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Multiple Sclerosis", 
                "Muscle Spasticity", 
                "Sclerosis"
            ]
        }, 
        "detailed_description": {
            "textblock": "Eligible patients entered this 50 week multicenter, double-blind, randomised,\n      placebo-controlled, parallel group study which evaluated the effect of Sativex on cognitive\n      performance. At each scheduled clinic visit, patients were assessed for cognitive\n      performance, mood, severity of spasticity, use of investigational medicinal products and\n      number of visits to a healthcare professional. Primary efficacy comparisons were made\n      between scores recorded during baseline and scores recorded at the end of treatment."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria (ALL to be fulfilled):\n\n          -  Patient is willing and able to give informed consent for participation in the study.\n\n          -  Patient is aged 18 years or above.\n\n          -  Diagnosed with any disease sub-type of multiple sclerosis.\n\n          -  Diagnosed with symptomatic spasticity due to multiple sclerosis.\n\n          -  Patient has at least moderate spasticity in the opinion of the investigator.\n\n          -  Patient fulfils at least one of the two criteria below. Subject must be either:\n\n               -  Currently established on a regular dose of anti-spasticity therapy, or\n\n               -  Previously tried and failed anti-spasticity therapy.\n\n          -  Stable medication regimen for at least four weeks prior to study entry, for all\n             medications which may have an effect on spasticity and/or cognition.\n\n          -  If the patient is taking disease modifying medication this must be at a stable dose\n             for three months prior to the initial visit.\n\n          -  Willing and able to comply with all study requirements.\n\n          -  Willing for his or her name to be notified to the responsible authorities for\n             participation in this study, as applicable.\n\n          -  Willing to allow his or her primary care practitioner and consultant, if appropriate,\n             to be notified of participation in the study.\n\n        Exclusion Criteria (if ANY apply):\n\n          -  Any history or immediate family of schizophrenia, other psychotic illness, severe\n             personality disorder or other significant psychiatric disorder other than depression\n             associated with their underlying condition.\n\n          -  Any concomitant disease or disorder (such as poorly controlled epilepsy or seizures)\n             that may influence the patient's level of cognition or mood.\n\n          -  Currently using or has used cannabis or cannabinoid-based medications within 30 days\n             of study entry and unwilling to abstain for the duration of the study.\n\n          -  Any known or suspected history of a diagnosed dependence disorder, current heavy\n             alcohol consumption (more than 60g of pure alcohol per day for men, and more than 40g\n             of pure alcohol per day for women), current use of an illicit drug or current\n             non-prescribed use of any prescription drug.\n\n          -  Any known or suspected hypersensitivity to cannabinoids or any of the excipients of\n             the investigational medicinal products.\n\n          -  Female patients of child bearing potential and male subjects whose partner is of\n             child bearing potential, unless willing to ensure that they or their partner use\n             effective contraception during the study and for three months thereafter.\n\n          -  Female patient who is pregnant, lactating or planning pregnancy during the course of\n             the study and for three months thereafter.\n\n          -  Patients who have received an investigational medicinal product within the 12 weeks\n             prior to the initial visit.\n\n          -  Any other significant disease or disorder which, in the opinion of the investigator,\n             may either put the patient at risk because of participation in the study may\n             influence the result of the study, or the patient's ability to participate in the\n             study.\n\n          -  Following a physical examination, the patient has any abnormalities that, in the\n             opinion of the investigator would prevent the patient from safe participation in the\n             study.\n\n          -  Previously randomised to this study."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "121", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "October 15, 2013", 
        "firstreceived_results_date": "October 29, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01964547", 
            "org_study_id": "GWMS1137"
        }, 
        "intervention": [
            {
                "arm_group_label": "Sativex", 
                "description": "Patients self-administered their allocated randomized treatment on an outpatient basis, up to a maximum of 12 sprays to the oral mucosa per day (following an initial titration period).", 
                "intervention_name": "Sativex", 
                "intervention_type": "Drug", 
                "other_name": [
                    "Nabiximols", 
                    "GWP42001", 
                    "THC/CBD spray"
                ]
            }, 
            {
                "arm_group_label": "Placebo", 
                "description": "Patients self-administered their allocated randomized treatment on an outpatient basis, up to a maximum of 12 sprays to the oral mucosa per day (following an initial titration period).", 
                "intervention_name": "Placebo", 
                "intervention_type": "Drug", 
                "other_name": "Placebo control"
            }
        ], 
        "is_fda_regulated": "No", 
        "keyword": [
            "Cognition", 
            "Mood"
        ], 
        "lastchanged_date": "April 2, 2014", 
        "link": {
            "description": "P1206: Abstract of study data presented at ECTRIMS 2013", 
            "url": "http://msj.sagepub.com/content/19/11_suppl/559.full"
        }, 
        "location": {
            "facility": {
                "address": {
                    "city": "Prague", 
                    "country": "Czech Republic", 
                    "zip": "128 08"
                }, 
                "name": "MS Centre, Charles University"
            }
        }, 
        "location_countries": {
            "country": "Czech Republic"
        }, 
        "number_of_arms": "2", 
        "official_title": "A Multicentre, Double-blind, Randomised, Parallel Group, Placebo-controlled Study of the Effect of Long-term Treatment With Sativex on Cognitive Function and Mood of Patients With Spasticity Due to Multiple Sclerosis", 
        "overall_official": {
            "affiliation": "Charles University, Czech Republic", 
            "last_name": "Iveta Nov\u00e1kov\u00e1, MD MBBS", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "Czech Republic: State Institute for Drug Control", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 4", 
        "primary_completion_date": {
            "#text": "May 2013", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "description": "The PASAT is a measure of cognitive function that specifically assesses auditory information processing speed and flexibility, as well as calculation ability. Stimulus presentation rates were adapted for use with multiple sclerosis patients. The PASAT is presented on audio compact disk to control the rate of stimulus presentation. Single digits are presented either every 3 seconds (PASAT 1) or every 2 seconds (PASAT 2), and the patient must add each new digit to the one immediately prior to it. The test score is the sum of the total number of correct sums given (out of 60 possible) in each trial. An increase in score indicates an improvement in condition.", 
            "measure": "Change From Baseline to the End of Treatment in Paced Auditory Serial Addition Test (PASAT) Total Score.", 
            "safety_issue": "Yes", 
            "time_frame": "0-48 weeks"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01964547"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "results_reference": {
            "PMID": "24151639", 
            "citation": "Abstracts of ECTRIMS (Congress of the European Committee for Treatment and Research in Multiple Sclerosis) 2013. October 2-5, 2013. Copenhagen, Denmark. Mult Scler. 2013 Oct;19(11 Suppl):8-597."
        }, 
        "secondary_outcome": [
            {
                "description": "The BDI-II is a multiple choice self-reported inventory that is one of the most widely used instruments for measuring the severity of depression. There are 21 questions or items, each having four possible responses. Each response is assigned a score ranging from zero to three, indicating the severity of the symptom. Items 1 to 13 assess symptoms that are psychological in nature, while items 14 to 21 assess symptoms that are more physical. The sum of all BDI-II item scores indicates the severity of depression. For patients eligible for this study, a score of 21 or over represents depression. The BDI-II can distinguish between different subtypes of depressive disorders, such as major depression and dysthymia. A reduction in score indicates an improvement in condition.", 
                "measure": "Change From Baseline to the End of Treatment in Beck Depression Inventory-II (BDI-II) Total Score.", 
                "safety_issue": "Yes", 
                "time_frame": "0-48 weeks"
            }, 
            {
                "description": "Patients were asked the following question, to be rated on a seven-point scale:\n\"Please assess the change in your spasticity since immediately before receiving the first dose of study treatment (Visit 1) using the scale below\".\nThe markers were: 'Very much worse', 'Much worse', 'Minimally worse', 'No change', 'Minimally better', 'Much better' or 'Very much better'.\nThe number of patients for each of the markers is presented at the final study visit.", 
                "measure": "Subject Global Impression of Change (SGIC) in the Severity of Their Spasticity at the End of Treatment.", 
                "safety_issue": "No", 
                "time_frame": "0-48 weeks"
            }, 
            {
                "description": "Caregivers were asked the following question to be rated on a seven-point scale:\n\"How has the subject's spasticity changed since Visit 1?\" The markers were: Very much worse, Much worse, Minimally worse, No change, Minimally better, Much better, Very much better.\nThe number of patients for each of the markers is presented at the final study visit.", 
                "measure": "Caregiver's Global Impression of Change (CGIC) in the Severity of the Patient's Spasticity at the End of Treatment.", 
                "safety_issue": "No", 
                "time_frame": "0-48 weeks"
            }, 
            {
                "description": "Physicians were asked the following question to be rated on a seven-point scale:\n\"How has the subject's spasticity changed since Visit 1?\" The markers were: Very much worse, Much worse, Minimally worse, No change, Minimally better, Much better, Very much better.\nThe number of patients for each of the markers is presented at the final study visit.", 
                "measure": "Physician's Global Impression of Change (PGIC) in the Severity of the Patient's Spasticity at the End of Treatment.", 
                "safety_issue": "No", 
                "time_frame": "0-48 weeks"
            }, 
            {
                "description": "All 20 muscle groups were assessed for spasticity (using a 0-5 scale): 0= 'no increase in muscle tone' to 5= 'affected part(s) rigid in flexion or extension'. The score for all 20 muscle groups were added to give a total score out of 100. A decrease in score indicates an improvement in condition.", 
                "measure": "Change From Baseline to End of Treatment in Modified Ashworth Scale Total Score.", 
                "safety_issue": "No", 
                "time_frame": "0-48 weeks"
            }, 
            {
                "description": "At baseline, patients were asked how many times they had visited a healthcare professional in the previous 12 weeks. At subsequent visits, patients were asked how many times they had visited a healthcare professional since their last study visit. The change from baseline to the end of treatment is presented. A decrease in number indicates an improvement in condition.", 
                "measure": "Change From Baseline to End of Treatment in Number of Visits to a Healthcare Professional.", 
                "safety_issue": "No", 
                "time_frame": "0-48 weeks"
            }, 
            {
                "description": "Patients were scored at each clinic visit for the following outcomes using the C-SSRS: suicidal ideation, suicidal behaviour, suicidality (including complete suicidality). Possible flags were as follows: \"Wish to be Dead\", \"Non-specific Active Suicidal Thoughts\", \"Active Suicidal Ideation Without Intent\", \"Active Suicidal Ideation With Intent, No Plan\", \"Active Suicidal Ideation With Intent and Plan\". The number of patients with a treatment-emergent flag is presented.", 
                "measure": "The Number of Patients With a Treatment-emergent Flag Using the Columbia-Suicide Severity Rating Scale (C-SSRS) During the Course of the Study.", 
                "safety_issue": "Yes", 
                "time_frame": "0-48 weeks"
            }, 
            {
                "description": "Only those patients for whom it was appropriate (i.e. ambulatory patients) were timed for how long it took to walk 10 metres. If a patient started the 10-meter walk but was unable to complete it, an estimated time for completion was calculated based on the available data. A negative difference from baseline indicates an improvement in condition.", 
                "measure": "Change From Baseline to End of Treatment in Timed 10-meter Walk Times.", 
                "safety_issue": "No", 
                "time_frame": "0-48 weeks"
            }, 
            {
                "description": "The number of subjects who experienced an adverse event during the course of the study is presented.", 
                "measure": "Incidence of Adverse Events as a Measure of Patient Safety.", 
                "safety_issue": "Yes", 
                "time_frame": "0-50 weeks"
            }
        ], 
        "source": "GW Pharmaceuticals Ltd.", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "GW Pharmaceuticals Ltd.", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "January 2012", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "April 2014"
    }
}